SEC Filing Summary: eXegenics Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by eXegenics Inc., a Delaware corporation, on November 14, 2002. The report serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The filing primarily addresses Item 9 (Regulation FD Disclosure) and includes a certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 regarding the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2002.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document is a certification of compliance rather than a financial statement. It confirms that the previously filed Form 10-Q for the quarter ended September 30, 2002, fairly presents the financial condition and results of operations, but does not restate those figures within this 8-K.
Material Changes
No material changes to financial results or operations are detailed in this specific filing. The document focuses on the legal certification that the prior quarter's report (Form 10-Q) complies with SEC requirements.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future outlook, or specific discussion of risks and contingencies beyond the standard legal certification. The document certifies that the Form 10-Q fully complies with the Securities Exchange Act of 1934.
Key Facts for Investor Verification
- Company Identity: The registrant is eXegenics Inc., not OPKO Health, Inc. (Note: The input metadata listed OPKO Health, but the filing text explicitly names eXegenics Inc.).
- Certification Scope: The filing certifies the accuracy of the Form 10-Q for the quarter ended September 30, 2002.
- Signatories: The report was signed by Ronald L. Goode (Principal Executive Officer) and Joan H. Gillett (Principal Financial Officer).
- Financial Data Source: Investors must refer to the separate Form 10-Q filing for the quarter ended September 30, 2002, to obtain actual financial metrics, as they are not included in this 8-K.